GSK, Britain’s second-biggest drugmaker, has unveiled better-than-expected results for the first three months of the year, ahead of the planned July listing of its consumer healthcare division, which makes Sensodyne toothpaste and Panadol painkillers.
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:
Go ahead